Dr. Lawrence D. Kaplan, MD

Dr. Kaplan practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Kaplan's NPI, 1437113586, was assigned on April 14, 2006. Dr. Kaplan graduated from David Geffen School of Medicine at UCLA in 1980. Dr. Kaplan's California license number on file is G51737.

Dr. Kaplan's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Kaplan's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Kaplan to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaplan practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Kaplan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kaplan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kaplan has a license on file in California.

Dmand AI lists chronic leukemia, immune deficiency disease, lymphoma and purpura and thrombocytopenia among the conditions Dr. Kaplan treats.

CMS data shows 115 Medicare services from Dr. Kaplan across 2 procedure codes in 2024, all of them office visits, for 63 Medicare patients. Medicare paid $9,638 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 63 Medicare patients who saw Dr. Kaplan in 2024. The largest group is 65 to 74, with 26 patients. 65% of them have high cholesterol, and 56% have high blood pressure. 19% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaplan's median patient age at 73, with 49% women.

In 2024, Dr. Kaplan wrote 142 Medicare Part D claims for 20 patients. 29% of them were for generic drugs. CMS names the drug for 115 of them, across 4 drugs with 11 or more claims each, at $1,485,782 in total drug cost. In 2023, CMS named 118 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Kaplan for performance year 2024, reported as part of a group. Dr. Kaplan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaplan as offering telehealth.

Dmand AI links 79 papers to Dr. Kaplan, published from 2005 to 2023. 2013 was the busiest year, with 3. The most frequent topics are Lymphoma, AIDS-Related, Acquired Immunodeficiency Syndrome and Antineoplastic Combined Chemotherapy Protocols. Dr. Kaplan has published most often in J Clin Oncol. Dr. Kaplan's most frequent co-authors are Paul A. Volberding, MD, Donald Ira Abrams, MD and Charalambos I. Andreadis, MD.

Dmand AI links Dr. Kaplan to 8 clinical trials, 4 of them phase 2 studies. Conditions studied include Lymphoma, Non-Hodgkin, Burkitt Lymphoma and Lymphoma. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 11 general payments to Dr. Kaplan from 6 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 83% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $4,464.

Dmand AI lists 4 awards for Dr. Kaplan, most recently America's Top Doctors in 2014.

Dr. Kaplan graduated from David Geffen School of Medicine at UCLA in 1980. Dr. Kaplan is a member of ASCO and ASH.

Dr. Kaplan is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.